Effects of dapagliflozin according to QRS duration across the spectrum of LVEF: An analysis of DAPA-HF and DELIVER

31 August 2024 (09:30 - 09:40)
Organised by: Logo
Congress Presentation Part of: Further Insights into SGLT2i treatment for heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by